Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...
12d
Clinical Trials Arena on MSNOrca Bio makes a splash as T-cell therapy cuts GvHD in blood cancer patientsGraft versus host disease (GvHD) is a complication from stem cell transplants where the patient recognises the cells as ...
It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...
In treating hematologic malignancies, engineered T-cell therapy outperforms standard transplantation with respect to chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results